IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3

Clinical trial NCT03267680 · TERMINATED

Trial details

NCT number: NCT03267680
Sponsor: University of Southern California
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Squamous Cell Carcinoma In Situ Vulvar High Grade Squamous Intraepithelial Lesion

Start date: 2017-11-08
Primary completion: 2023-08-04
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.